Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure

Introduction: Biosimilar medicines are considered promising alternatives to new biologicals with high price tags. The extent of savings resulting from biosimilar use depends on their price and uptake, which are largely shaped by pricing, reimbursement, and demand-side policies. This article informs...

Celý popis

Podrobná bibliografia

Vydané v:	Frontiers in pharmacology Ročník 12; s. 625296
Hlavní autori:	Vogler, Sabine, Schneider, Peter, Zuba, Martin, Busse, Reinhard, Panteli, Dimitra
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Frontiers Media S.A 25.06.2021
Predmet:	biological biosimilar cross-country comparison Pharmacology policy measure savings substitution
ISSN:	1663-9812, 1663-9812
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!